ArticleJournal of applied biomedicine2026
Genetic polymorphisms in the SLC27A5 gene are associated with biochemical characteristics of HBV patients in Yunnan.
Article in Journal of applied biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundLipid droplets could influence hepatitis B virus (HBV) replication and release, as well as disease progression in patients with chronic HBV. The solute carrier family 27 member 5 (SLC27A5) gene is highly expressed in the liver and possessed bile acid-CoA ligase activity. However, no previous study has investigated the role of the SLC27A5 gene in HBV infection or disease progression.
methodsA total of 400 chronic HBV patients and 300 controls were collected in Yunnan Province to genotype three single nucleotide polymorphisms (SNPs) of the SLC27A5 gene and investigate potential association between SNPs and HBV infection or biochemical characteristics of HBV patients. In silico prediction and dual-luciferase reporter assay were performed to explore the role of alleles of each SNP.
resultsNo association was found between HBV infection and genotypes and alleles of three SNPs (rs4801275, rs2278497, and rs56225452) in the SLC27A5 gene. However, alanine transaminase (ALT) and lymphocytes (LYM) levels differed significantly among HBV patients carrying different genotypes of rs4801275. When HBV patients were stratified into HBsAg-positive and HBsAg-negative subgroups, most hepatic functional features showed significant differences between the two subgroups. Furthermore, RNA structures containing the alleles of two SNPs were predicted, and the results indicated that different alleles could partially alter RNA structures. Dual-luciferase reporter assay also demonstrated that different alleles of the three SNPs significantly influenced firefly luciferase expression level.
conclusionThis study is the first to identify that genetic polymorphisms of the SLC27A5 gene are associated with biochemical characteristics of HBV patients in Yunnan. Furthermore, the RNA structure prediction and dual-luciferase reporter assays suggest that different alleles of the three SNPs might alter the SLC27A5 gene expression levels.
Indexed as
Identifiers
42808827What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.